https://www.prnewswire.com/news-releases/rosen-trusted-investor-counsel-encourages-annovis-bio-inc-investors-with-losses-to-secure-counsel-before-important-deadline--anvs-301359084.html
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Annovis Bio, Inc. Investors with Losses to Secure...
/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the...
https://www.biospace.com/annovis-bio-secures-u-s-patent-for-treatment-of-acute-traumatic-brain-injury-with-buntanetap
Annovis Bio Secures U.S. Patent for Treatment of Acute Traumatic Brain Injury with Buntanetap -...
https://www.macrotrends.net/stocks/charts/ANVS/annovis-bio/dividend-yield-history
Annovis Bio - 55 Year Dividend History | ANVS | MacroTrends
Historical dividend payout and yield for Annovis Bio (ANVS) since 1971. The current TTM dividend payout for Annovis Bio (ANVS) as of May 18, 2026 is...
dividend historyannovisbio55year
https://www.prnewswire.com/news-releases/annovis-bio-announces-second-quarter-2022-results-and-provides-corporate-update-301601125.html
Annovis Bio Announces Second Quarter 2022 Results and Provides Corporate Update
/PRNewswire/ -- Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a clinical-stage drug platform company addressing neurodegenerative diseases,...
second quarter2022 resultsannovisbioannounces
https://www.newsfilecorp.com/company/7656/Annovis-Bio-Inc.
Annovis Bio, Inc. | TMX Newsfile
Annovis Bio, Inc. at TMX Newsfile
annovisbioinctmxnewsfile
https://www.sofi.com/invest/stock/ANVS/
Buy Annovis Bio Stock - ANVS Stock Price, Quote & News | SoFi
See real time price charts for ANVS stock, historical data, and recent news. Buy ANVS stock online with no commission fees.
price quotebuyannovisbiostock
https://www.newsfilecorp.com/release/122063/Annovis-Bio-Announces-Cooperative-Research-and-Development-Agreement-CRADA-with-the-National-Institute-on-Aging
Annovis Bio Announces Cooperative Research and Development Agreement (CRADA) with the National...
Berwyn, Pennsylvania--(Newsfile Corp. - April 28, 2022) - Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a clinical-stage drug...
research and development
https://www.biospace.com/annovis-bio-ceo-maria-maccecchini-issues-letter-to-stockholde
Annovis Bio CEO Maria Maccecchini Issues Letter to Stockholde - BioSpace
Dec 20, 2021 - I believe ongoing communications with you is my responsibility; therefore, I wanted to take this opportunity to review our accomplishments over the past year...
annovisbioceomariaissues
https://www.biospace.com/annovis-bio-files-provisional-patent-for-new-manufacturing-process-of-crystalline-form-of-buntanetap
Annovis Bio Files Provisional Patent for New Manufacturing Process of Crystalline Form of...
Aug 7, 2024 - Annovis Bio Inc. announced the filing of a provisional patent covering the manufacturing process of new solid forms of buntanetap.
provisional patent
https://www.benzinga.com/news/21/07/22228104/44-stocks-moving-in-thursdays-mid-day-session
44 Stocks Moving In Thursday's Mid-Day Session - Annovis Bio (NYSE:ANVS) - Benzinga
Jul 29, 2021 - Gainers NanoVibronix, Inc. (NASDAQ: NAOV) shares jumped 47.6% to $2.8198 after the company announced it received registration approval for UroShield from TGA...